Technology
Happen, Inc. Reports Second Quarter 2026 Results
Published
3 months agoon
By
Record $75.7 Million Pre-Tax Income, 15.1% ROE, and 15.9% ROTCE
Grew Originations 29% Year-over-Year; Increased Diluted EPS 52% Year-over-Year to $0.50
Successfully Rebranded to Happen Bank (Nasdaq: HAPN) from LendingClub
SAN FRANCISCO, July 27, 2026 /PRNewswire/ — Happen, Inc. (Nasdaq: HAPN), parent company of Happen Bank, a digital bank built for the Motivated Middle, today announced financial results for the second quarter ended June 30, 2026.
“Happen delivered a standout quarter, growing originations 29% year-over-year to $3.1 billion, while producing record pre-tax income of $75.7 million and a return on tangible common equity of 15.9%,” said Scott Sanborn, CEO, Happen, Inc. “This is our first quarter operating under the Happen Bank brand, and our results demonstrate exactly what the brand represents: forward momentum. Our core business is firing on all cylinders. We’re ramping our entry into the $500 billion home improvement market and we’re innovating on behalf of our members, all while growing earnings and increasing returns for our shareholders.”
Second Quarter 2026 Results
Highlights:
Launched the new Happen Bank brand.Transferred stock listing from NYSE: LC to Nasdaq: HAPN.Delivering growth across consumer businesses.Began originating loans in the home improvement market.Continued multi-year credit outperformance vs. competitor set, with over 40% lower delinquencies.Record >90% automation rate and AI-powered agent support tools led to record originations efficiency.Executed $12 million of the $100 million Stock Repurchase and Acquisition Program, with cumulative utilization through June totaling $50 million.
Balance Sheet:
Total assets of $12.5 billion, up 16% year-over-year, primarily due to growth in loans and securities.Deposits of $10.8 billion, up 18% year-over-year, with 88% of deposits FDIC-insured.Robust available liquidity of $4.1 billion.Strong capital position with a consolidated Tier 1 leverage ratio of 11.9% and a CET1 capital ratio of 16.9%.
Financial Performance:
Achieved $3.1 billion in origination volume, up 29% compared to the prior year, driven by the successful execution of product and marketing initiatives.Total net revenue increased 6% to $262.9 million, compared to $248.4 million in the prior year, driven by higher loan origination volume and higher net interest income.Provision benefit of $10.9 million, compared to an expense of $39.7 million in the prior year, due to strong credit performance and the 2026 election of fair value option (FVO) accounting for all new originations.Net charge-offs on total loans and leases held for investment improved to $40.6 million, compared to $46.1 million in the same quarter in the prior year, supported by strong credit performance.Net income and Diluted EPS grew 52% to $58.1 million and $0.50, respectively, compared to $38.2 million and $0.33 in the prior year, respectively.Profit margin (pre-tax) of 28.8%, compared to 21.7% in the prior year.Return on Equity (ROE) of 15.1% with a Return on Tangible Common Equity (ROTCE) of 15.9%.
Summary Financial Highlights:
Three Months Ended
($ in millions, except per share amounts)
June 30,
2026
March 31,
2026
June 30,
2025
Total net revenue
$ 262.9
$ 252.3
$ 248.4
Provision for credit losses
(10.9)
0.4
39.7
Non-interest expense
198.1
184.5
154.7
Income before income tax expense
75.7
67.3
54.0
Income tax expense
(17.5)
(15.7)
(15.8)
Net income
$ 58.1
$ 51.6
$ 38.2
Diluted EPS
$ 0.50
$ 0.44
$ 0.33
For a calculation of Tangible Book Value Per Common Share and Return on Tangible Common Equity, refer to the “Reconciliation of GAAP to Non-GAAP Financial Measures” tables at the end of this release.
2026 Strategic Priorities & Investments
Happen has made important progress on several strategic initiatives:
Corporate Rebrand: Rebranded to Happen BankTM, a bank that clears the way for people going places, providing fast and easy access to award-winning products that help them save more of what they earn and earn more on what they save. The new brand reflects the company’s transition from a pioneering online lender to a diversified digital-first bank that combines deposits, lending, and a capital-light marketplace bank model. The company completed the transition and began trading on Nasdaq under HAPN in June 2026.
Home Improvement Financing: Having previously acquired foundational technology and key talent, Happen Bank is now underwriting and originating home improvement loans and the pipeline of additional new partners is significant. Home improvement is a $500 billion market where Happen Bank has distinct advantages over incumbents and a meaningful opportunity for growth.
AI and Operating Efficiency: The company has multiple AI initiatives underway across marketing, product, engineering, operations, customer experience, and compliance, with the goal of improving member experience, driving efficiency, and supporting margin expansion over time. AI-powered automation and agent support tools have already led to record personal loans originations production efficiency and a record-high >90% automation rate for issued loans.
New Marketing Channel Investment: The company accelerated investments in new acquisition channels, including paid social and display, ahead of normal seasonal timing in order to build attribution models and data capabilities for the full-year 2026 growth plan. Successful execution of marketing and product initiatives contributed to a 29% year-over-year increase in originations in the second quarter.
Transition to Fair Value Option Accounting: Starting January 1, 2026, Happen Bank adopted FVO accounting for all new originations of loans held for investment. This change aligns the accounting treatment for loans held for investment and held for sale, creating a consistent framework across the business and better aligns the timing of revenue recognition with the timing of credit and operational expenses. The company expects this transition will, over time, result in higher return on invested capital.
From a financial reporting perspective, under FVO, new loans are marked to fair value at origination, with subsequent changes in fair value, reflecting both credit performance and market conditions, flowing through non-interest income each quarter rather than through a separate provision for credit losses. The company will no longer record a CECL provision on new loan originations.
Financial Outlook
Third Quarter 2026
Loan originations
$3.20B to $3.35B
Diluted EPS
$0.43 to $0.48
Full Year 2026
Loan originations
$12.2B to $12.6B
Diluted EPS
$1.80 to $1.90
About Happen Bank
Happen Bank™ – formerly LendingClub Bank – is a digital bank built for the Motivated Middle: high-FICO, high-income, digitally savvy consumers actively managing their financial lives. Our difference? We make it easy for them to access award-winning products that help them keep more of what they earn and earn more on what they save. Our products are aligned by design to reward our five million plus members when they take positive financial steps, like saving regularly or making loan payments on time.
The Company’s success is fueled by our advanced credit underwriting, a proprietary technology platform engineered for innovation, and a marketplace bank model that drives value for members, loan investors, and shareholders alike. The result is affordable credit, meaningful value, and a trusted banking relationship – delivered consistently and profitably at scale.
Happen Bank exists to clear the way for our members to make it happen.
Happen, Inc. (Nasdaq: HAPN) – formerly LendingClub Corporation – is the parent company and operator of Happen Bank, National Association, Member FDIC. For more information about Happen Bank, visit https://www.happen.com.
Conference Call and Webcast Information
Happen, Inc.’s second quarter 2026 webcast and teleconference is scheduled to begin at 2:00 p.m. Pacific Time (or 5:00 p.m. Eastern Time) on Monday, July 27, 2026. A live webcast of the call will be available at https://ir.happen.com under News & Events menu. To listen to the call, register using this link: https://edge.media-server.com/mmc/p/n9sxvwro ten minutes prior to 2:00 p.m. Pacific Time (or 5:00 p.m. Eastern Time). An audio archive of the call will be available at https://ir.happen.com. Happen, Inc. communicates with its investors and the public, including by disclosing material information pursuant to Regulation FD, through various channels, including its website (including the investor relations page at https://ir.happen.com), social media (including X, LinkedIn and Facebook), filings with the Securities and Exchange Commission, press releases, conference calls and webcasts. Accordingly, we encourage investors and the public to review our communications across all channels.
Question Submissions
Prior to quarterly earnings, investors have the ability to submit and upvote questions for Happen Bank’s management team to consider. To participate, visit the link provided in each quarter’s earnings date announcement.
Contacts
For Investors:
IR@happen.com
Media Contact:
Press@happen.com
Non-GAAP Financial Measures
To supplement our financial statements, which are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measures: Tangible Book Value (TBV) Per Common Share and Return on Tangible Common Equity (ROTCE). Our non-GAAP financial measures do have limitations as analytical tools and you should not consider them in isolation or as a substitute for an analysis of our results under GAAP.
We believe these non-GAAP financial measures provide management and investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies.
We believe TBV Per Common Share is an important measure used to evaluate the company’s use of equity. TBV Per Common Share is a non-GAAP financial measure representing tangible common equity for the period (common equity reduced by goodwill and customer relationship intangible assets), divided by the ending number of common shares issued and outstanding.
We believe ROTCE is an important measure because it reflects the company’s ability to generate income from its core assets. ROTCE is a non-GAAP financial measure calculated by dividing annualized net income by the average tangible common equity for the applicable period.
For a reconciliation of such measures to the nearest GAAP measures, please refer to the tables on page 11 of this release.
Safe Harbor Statement
Some of the statements above, including statements regarding our entry into home improvement financing, our AI initiatives, the impact of the transition to fair value option accounting and anticipated future performance and financial results, are “forward-looking statements.” The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “outlook,” “plan,” “predict,” “project,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, although not all forward-looking statements contain these identifying words. Factors that could cause actual results to differ materially from those contemplated by these forward-looking statements include: our loan performance, our ability to continue to attract and retain new and existing borrowers and marketplace investors (including retaining long-term investors through the duration of their expected partnership and achieving the anticipated level of purchases); competition; overall economic conditions; our ability to integrate acquired technology; the interest rate and/or regulatory environment; default rates and those factors set forth in the section titled “Risk Factors” in our most recent Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, as well as in our subsequent filings with the Securities and Exchange Commission. Actual results or events could differ materially from the plans, intentions and expectations disclosed in forward-looking statements, and you should not place undue reliance on forward-looking statements. We do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
HAPPEN, INC.
OPERATING HIGHLIGHTS
(In thousands, except percentages or as noted)
(Unaudited)
As of and for the three months ended
% Change
June 30,
2026
March 31,
2026
December 31,
2025
September 30,
2025
June 30,
2025
Q/Q
Y/Y
Operating Highlights:
Net interest income
$ 179,017
$ 176,234
$ 163,027
$ 158,439
$ 154,249
2 %
16 %
Non-interest income
83,838
76,017
103,444
107,792
94,186
10 %
(11) %
Total net revenue
262,855
252,251
266,471
266,231
248,435
4 %
6 %
Provision for credit losses
(10,917)
390
47,158
46,280
39,733
N/M
N/M
Non-interest expense
198,115
184,533
169,284
162,713
154,718
7 %
28 %
Income before income tax expense
75,657
67,328
50,029
57,238
53,984
12 %
40 %
Income tax expense
(17,509)
(15,725)
(8,475)
(12,964)
(15,806)
11 %
11 %
Net income
$ 58,148
$ 51,603
$ 41,554
$ 44,274
$ 38,178
13 %
52 %
Diluted EPS
$ 0.50
$ 0.44
$ 0.35
$ 0.37
$ 0.33
14 %
52 %
Total loan originations (in millions)(1)
$ 3,145
$ 2,669
$ 2,637
$ 2,656
$ 2,433
18 %
29 %
Current period originations sold or held for sale
$ 2,039
$ 1,717
$ 2,090
$ 2,027
$ 1,702
19 %
20 %
Current period originations held for investment
$ 1,107
$ 952
$ 547
$ 629
$ 731
16 %
51 %
Total servicing portfolio (in millions)(2)
$ 14,596
$ 13,854
$ 13,423
$ 12,986
$ 12,524
5 %
17 %
Loans serviced for others
$ 8,231
$ 7,750
$ 7,601
$ 7,612
$ 7,185
6 %
15 %
Performance Metrics:
Net interest margin
6.14 %
6.28 %
5.98 %
6.18 %
6.14 %
Profit margin(3)
28.8 %
26.7 %
18.8 %
21.5 %
21.7 %
Return on average equity (ROE)(4)
15.1 %
13.7 %
11.3 %
12.4 %
11.1 %
Return on tangible common equity (ROTCE)(5)(6)
15.9 %
14.5 %
11.9 %
13.2 %
11.8 %
Return on average total assets (ROA)(7)
1.9 %
1.8 %
1.5 %
1.7 %
1.5 %
Marketing expense as a % of loan originations(1)
1.99 %
2.08 %
1.73 %
1.53 %
1.38 %
Average balance – total loans and leases held for investment
$ 5,108,678
$ 4,797,639
$ 4,767,573
$ 4,890,619
$ 4,899,272
6 %
4 %
Net charge-offs – total loans and leases held for investment
$ 40,599
$ 42,493
$ 47,852
$ 41,899
$ 46,078
(4) %
(12) %
Net charge-off ratio – total loans and leases held for investment(8)
3.2 %
3.5 %
4.0 %
3.4 %
3.8 %
Capital Metrics:
Common equity Tier 1 capital ratio
16.9 %
17.0 %
17.4 %
18.0 %
17.5 %
Tier 1 leverage ratio
11.9 %
11.9 %
12.0 %
12.3 %
12.2 %
Book value per common share
$ 13.58
$ 13.19
$ 13.01
$ 12.68
$ 12.25
3 %
11 %
Tangible book value per common share(6)
$ 12.89
$ 12.49
$ 12.30
$ 11.95
$ 11.53
3 %
12 %
(1)
Beginning in the first quarter of 2026, includes all loans originated during the respective periods (unsecured consumer loans, auto loans and small business loans). Previously this included unsecured consumer loans and auto loans only. In the second and first quarters of 2026, this update included small business loan originations of $38 million and $15 million, respectively. Prior periods have been reclassified to conform to the current period presentation.
(2)
Reflects loans serviced on our platform, which includes unsecured consumer loans and auto loans serviced for others for which servicing rights are retained by the company.
(3)
Calculated as the ratio of income before income tax expense to total net revenue.
(4)
Calculated as annualized net income divided by average equity for the period presented.
(5)
Calculated as annualized net income divided by average tangible common equity for the period presented.
(6)
Represents a non-GAAP financial measure. See “Reconciliation of GAAP to Non-GAAP Financial Measures.”
(7)
Calculated as annualized net income divided by average total assets for the period presented.
(8)
Beginning in the first quarter of 2026, the net charge-off ratio is calculated as annualized net charge-offs for total loans and leases held for investment (at amortized cost and fair value) divided by average total outstanding loans and leases held for investment during the period. Prior to the first quarter of 2026, this was calculated based on loans and leases held for investment at amortized cost only. Prior period amounts have been reclassified to conform to the current period presentation.
HAPPEN, INC.
OPERATING HIGHLIGHTS (Continued)
(In thousands, except percentages or as noted)
(Unaudited)
As of the period ended
% Change
June 30,
2026
March 31,
2026
December 31,
2025
September 30,
2025
June 30,
2025
Q/Q
Y/Y
Balance Sheet Data:
Securities available for sale
$ 4,046,761
$ 3,867,576
$ 3,706,709
$ 3,742,304
$ 3,527,142
5 %
15 %
Loans held for sale
$ 1,773,052
$ 1,836,121
$ 1,762,396
$ 1,213,140
$ 1,008,168
(3) %
76 %
Loans and leases held for investment
$ 5,078,318
$ 4,700,990
$ 4,470,383
$ 4,573,425
$ 4,765,068
8 %
7 %
Total loans and leases
$ 6,851,370
$ 6,537,111
$ 6,232,779
$ 5,786,565
$ 5,773,236
5 %
19 %
Total assets
$ 12,549,040
$ 11,939,839
$ 11,567,816
$ 11,072,515
$ 10,775,333
5 %
16 %
Total deposits
$ 10,765,267
$ 10,189,511
$ 9,833,870
$ 9,388,233
$ 9,136,124
6 %
18 %
Total liabilities
$ 10,981,575
$ 10,416,311
$ 10,067,388
$ 9,610,302
$ 9,369,298
5 %
17 %
Total equity
$ 1,567,465
$ 1,523,528
$ 1,500,428
$ 1,462,213
$ 1,406,035
3 %
11 %
HAPPEN, INC.
LOANS AND LEASES HELD FOR INVESTMENT BY DELINQUENCY STATUS
(In thousands)
(Unaudited)
The following tables present loans and leases held for investment (at amortized cost and fair value) by delinquency status(1):
June 30, 2026
Current
30-59
Days
60-89
Days
90 or More
Days
Total
Guaranteed
Amount (2)
Unsecured consumer (3)
$ 3,966,514
$ 19,724
$ 16,249
$ 14,386
$ 4,016,873
$ —
Residential mortgages
146,498
—
—
962
147,460
—
Secured consumer
406,339
2,378
741
157
409,615
—
Total consumer loans held for investment
4,519,351
22,102
16,990
15,505
4,573,948
—
Equipment finance (4)
29,827
—
—
3,422
33,249
—
Commercial real estate (5)
490,680
1,765
—
6,373
498,818
38,783
Commercial and industrial
136,122
2,560
2,888
23,230
164,800
115,001
Total commercial loans and leases held for investment
656,629
$ 4,325
$ 2,888
$ 33,025
$ 696,867
$ 153,784
Total loans and leases held for investment
$ 5,175,980
$ 26,427
$ 19,878
$ 48,530
$ 5,270,815
$ 153,784
December 31, 2025
Current
30-59
Days
60-89
Days
90 or More
Days
Total
Guaranteed
Amount (2)
Unsecured consumer (3)
$ 3,600,434
$ 24,075
$ 19,685
$ 18,929
$ 3,663,123
$ —
Residential mortgages
150,099
—
888
86
151,073
—
Secured consumer
257,063
3,015
596
395
261,069
—
Total consumer loans held for investment
4,007,596
27,090
21,169
19,410
4,075,265
—
Equipment finance (4)
35,973
696
—
3,088
39,757
—
Commercial real estate (5)
461,307
—
—
11,182
472,489
39,507
Commercial and industrial
133,526
1,540
1,878
20,074
157,018
108,826
Total commercial loans and leases held for investment
630,806
2,236
1,878
34,344
669,264
148,333
Total loans and leases held for investment
$ 4,638,402
$ 29,326
$ 23,047
$ 53,754
$ 4,744,529
$ 148,333
(1)
Beginning in the first quarter of 2026, amounts include loans and leases held for investment measured at both amortized cost and fair value. Prior to the first quarter of 2026, amounts included loans and leases held for investment at amortized cost only.
(2)
Represents loan balances guaranteed by the Small Business Association (SBA).
(3)
Excludes basis adjustment for loans previously designated in fair value hedges under the portfolio layer method of $0.4 million and $1.6 million as of June 30, 2026 and December 31, 2025, respectively.
(4)
Comprised of sales-type leases for equipment.
(5)
Includes $309.9 million and $286.8 million in loans originated through the SBA as of June 30, 2026 and December 31, 2025, respectively.
HAPPEN, INC.
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except share and per share data)
(Unaudited)
Three Months Ended
Change (%)
June 30,
2026
March 31,
2026
June 30,
2025
Q2 2026
vs
Q1 2026
Q2 2026
vs
Q2 2025
Interest income:
Interest on loans (1)
$ 206,397
$ 199,897
$ 174,645
3 %
18 %
Interest on securities available for sale
55,114
54,411
55,339
1 %
— %
Other interest income
7,424
6,899
7,113
8 %
4 %
Total interest income
$ 268,935
$ 261,207
$ 237,097
3 %
13 %
Interest expense:
Interest on deposits
89,916
84,971
82,845
6 %
9 %
Other interest expense
2
2
3
— %
(33) %
Total interest expense
89,918
84,973
82,848
6 %
9 %
Net interest income
179,017
176,234
154,249
2 %
16 %
Non-interest income:
Origination fees (2)
164,006
130,088
87,578
26 %
87 %
Servicing fees (2)
12,890
13,113
16,395
(2) %
(21) %
Gain on sales of loans (2)
21,461
16,269
13,540
32 %
59 %
Net fair value adjustments (2)
(121,145)
(88,925)
(27,869)
(36) %
(335) %
Other non-interest income
6,626
5,472
4,542
21 %
46 %
Total non-interest income
83,838
76,017
94,186
10 %
(11) %
Total net revenue
262,855
252,251
248,435
4 %
6 %
Provision for credit losses
(10,917)
390
39,733
N/M
N/M
Non-interest expense:
Compensation and benefits
68,221
65,514
61,989
4 %
10 %
Marketing
62,580
55,415
33,580
13 %
86 %
Equipment and software
15,846
15,293
14,495
4 %
9 %
Depreciation and amortization
18,152
15,819
15,460
15 %
17 %
Professional services
11,989
11,767
10,300
2 %
16 %
Occupancy
4,982
6,391
4,787
(22) %
4 %
Other non-interest expense
16,345
14,334
14,107
14 %
16 %
Total non-interest expense
198,115
184,533
154,718
7 %
28 %
Income before income tax expense
75,657
67,328
53,984
12 %
40 %
Income tax expense
(17,509)
(15,725)
(15,806)
11 %
11 %
Net income
$ 58,148
$ 51,603
$ 38,178
13 %
52 %
Net income per share:
Basic EPS
$ 0.50
$ 0.45
$ 0.33
11 %
52 %
Diluted EPS
$ 0.50
$ 0.44
$ 0.33
14 %
52 %
Weighted-average common shares – Basic
115,376,906
115,400,564
114,409,231
— %
1 %
Weighted-average common shares – Diluted
117,274,710
117,333,435
115,692,969
— %
1 %
(1)
Beginning in the first quarter of 2026, we combined “Interest on loans held for sale,” “Interest and fees on loans and leases held for investment,” and “Interest on loans held for investment at fair value,” into a single line item called “Interest on loans.” Prior period amounts have been reclassified to conform to the current period presentation.
(2)
Beginning in the first quarter of 2026, these components previously aggregated under “Marketplace revenue” on the Income Statement, are now presented as separate line items. Prior period amounts have been reclassified to conform to the current period presentation.
HAPPEN, INC.
NET INTEREST INCOME
(In thousands, except percentages or as noted)
(Unaudited)
Consolidated (1)
Three Months Ended
June 30, 2026
Three Months Ended
March 31, 2026
Three Months Ended
June 30, 2025
Average
Balance
Interest Income/
Expense
Average Yield/
Rate
Average
Balance
Interest Income/
Expense
Average Yield/
Rate
Average
Balance
Interest Income/
Expense
Average Yield/
Rate
Interest-earning assets (2)
Cash, cash equivalents,
restricted cash and other
$ 825,029
$ 7,424
3.60 %
$ 775,385
$ 6,899
3.56 %
$ 679,603
$ 7,113
4.19 %
Securities available for sale
at fair value
3,880,678
55,114
5.68 %
3,737,199
54,411
5.82 %
3,411,020
55,339
6.49 %
Loans held for sale at fair
value
1,850,763
64,039
13.84 %
1,910,017
64,531
13.51 %
1,061,845
32,489
12.24 %
Loans held for investment
at fair value
1,667,694
46,540
11.16 %
807,486
25,467
12.62 %
722,685
19,761
10.94 %
Loans and leases held for
investment at amortized
cost:
Unsecured consumer
loans
2,438,480
80,830
13.26 %
2,934,584
94,763
12.92 %
3,177,439
107,829
13.57 %
Commercial and secured
consumer loans
1,002,504
14,988
5.98 %
1,055,569
15,136
5.74 %
999,148
14,566
5.83 %
Loans and leases held for
investment at amortized
cost
3,440,984
95,818
11.14 %
3,990,153
109,899
11.02 %
4,176,587
122,395
11.72 %
Total loans and leases held
for investment
5,108,678
142,358
11.15 %
4,797,639
135,366
11.29 %
4,899,272
142,156
11.61 %
Total interest-earning assets
11,665,148
268,935
9.22 %
11,220,240
261,207
9.31 %
10,051,740
237,097
9.44 %
Cash and due from banks
and restricted cash
25,687
26,343
38,746
Allowance for loan and l
ease losses
(218,977)
(262,466)
(247,133)
Other non-interest earning
assets
695,671
668,486
633,711
Total assets
$ 12,167,529
$ 11,652,603
$ 10,477,064
Interest-bearing liabilities
Interest-bearing deposits (3):
Savings and money
market accounts
6,897,169
61,372
3.57 %
6,694,780
58,714
3.56 %
6,152,936
58,934
3.84 %
Certificates of deposit
2,736,658
27,381
4.01 %
2,488,015
25,174
4.10 %
1,997,980
22,469
4.51 %
Checking accounts
389,934
1,163
1.20 %
393,963
1,083
1.12 %
426,107
1,442
1.36 %
Interest-bearing deposits
10,023,761
89,916
3.60 %
9,576,758
84,971
3.60 %
8,577,023
82,845
3.87 %
Other interest-bearing
liabilities
220
2
3.81 %
222
2
3.79 %
220
3
4.54 %
Total interest-bearing liabilities
10,023,981
89,918
3.60 %
9,576,980
84,973
3.60 %
8,577,243
82,848
3.87 %
Noninterest-bearing
deposits
343,281
334,136
282,113
Other liabilities
256,029
233,776
236,509
Total liabilities
$ 10,623,291
$ 10,144,892
$ 9,095,865
Total equity
$ 1,544,238
$ 1,507,711
$ 1,381,199
Total liabilities and equity
$ 12,167,529
$ 11,652,603
$ 10,477,064
Interest rate spread
5.62 %
5.71 %
5.57 %
Net interest income and
net interest margin
$ 179,017
6.14 %
$ 176,234
6.28 %
$ 154,249
6.14 %
(1)
Consolidated presentation reflects intercompany eliminations.
(2)
Nonaccrual loans and any related income are included in their respective loan categories.
(3)
Prior period amounts have been reclassified to conform to the current period presentation.
HAPPEN, INC.
CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Share and Per Share Amounts)
(Unaudited)
June 30,
2026
December 31,
2025
Assets
Cash and due from banks
$ 11,957
$ 11,749
Interest-bearing deposits in banks
900,810
905,905
Total cash and cash equivalents
912,767
917,654
Restricted cash
15,455
12,783
Securities available for sale at fair value ($4,103,026 and $3,733,780 at amortized cost, respectively)
4,046,761
3,706,709
Loans held for sale at fair value
1,773,052
1,762,396
Loans held for investment at fair value
2,085,066
473,314
Loans and leases held for investment
3,186,145
4,272,812
Allowance for loan and lease losses
(192,893)
(275,743)
Loans and leases held for investment, net
2,993,252
3,997,069
Property, equipment and software, net
276,454
254,088
Goodwill
75,717
75,717
Other assets
370,516
368,086
Total assets
$ 12,549,040
$ 11,567,816
Liabilities and Equity
Deposits:
Interest-bearing
$ 10,336,236
$ 9,459,483
Noninterest-bearing
429,031
374,387
Total deposits
10,765,267
9,833,870
Other liabilities
216,308
233,518
Total liabilities
10,981,575
10,067,388
Equity
Common stock, $0.01 par value; 180,000,000 shares authorized; 115,407,464 and 115,368,987 shares issued and outstanding, respectively
1,154
1,154
Additional paid-in capital
1,697,357
1,719,233
Accumulated deficit
(92,048)
(201,799)
Accumulated other comprehensive loss
(38,998)
(18,160)
Total equity
1,567,465
1,500,428
Total liabilities and equity
$ 12,549,040
$ 11,567,816
HAPPEN, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(In thousands, except share and per share data)
(Unaudited)
Tangible Book Value Per Common Share
June 30,
2026
March 31,
2026
December 31,
2025
September 30,
2025
June 30,
2025
GAAP common equity
$ 1,567,465
$ 1,523,528
$ 1,500,428
$ 1,462,213
$ 1,406,035
Less: Goodwill
(75,717)
(75,717)
(75,717)
(75,717)
(75,717)
Less: Customer relationship intangible assets
(4,492)
(5,039)
(5,685)
(8,206)
(7,068)
Tangible common equity
$ 1,487,256
$ 1,442,772
$ 1,419,026
$ 1,378,290
$ 1,323,250
Book value per common share
GAAP common equity
$ 1,567,465
$ 1,523,528
$ 1,500,428
$ 1,462,213
$ 1,406,035
Common shares issued and outstanding
115,407,464
115,497,890
115,368,987
115,301,440
114,740,147
Book value per common share
$ 13.58
$ 13.19
$ 13.01
$ 12.68
$ 12.25
Tangible book value per common share
Tangible common equity
$ 1,487,256
$ 1,442,772
$ 1,419,026
$ 1,378,290
$ 1,323,250
Common shares issued and outstanding
115,407,464
115,497,890
115,368,987
115,301,440
114,740,147
Tangible book value per common share
$ 12.89
$ 12.49
$ 12.30
$ 11.95
$ 11.53
Return On Tangible Common Equity
For the three months ended
June 30,
2026
March 31,
2026
December 31,
2025
September 30,
2025
June 30,
2025
Average GAAP common equity
$ 1,544,238
$ 1,507,711
$ 1,473,356
$ 1,424,538
$ 1,381,199
Less: Average goodwill
(75,717)
(75,717)
(75,717)
(75,717)
(75,717)
Less: Average customer relationship intangible assets
(4,766)
(5,362)
(6,031)
(6,722)
(7,423)
Average tangible common equity
$ 1,463,755
$ 1,426,632
$ 1,391,608
$ 1,342,099
$ 1,298,059
Return on average equity
Annualized GAAP net income
$ 232,592
$ 206,412
$ 166,216
$ 177,096
$ 152,712
Average GAAP common equity
$ 1,544,238
$ 1,507,711
$ 1,473,356
$ 1,424,538
$ 1,381,199
Return on average equity
15.1 %
13.7 %
11.3 %
12.4 %
11.1 %
Return on tangible common equity
Annualized GAAP net income
$ 232,592
$ 206,412
$ 166,216
$ 177,096
$ 152,712
Average tangible common equity
$ 1,463,755
$ 1,426,632
$ 1,391,608
$ 1,342,099
$ 1,298,059
Return on tangible common equity
15.9 %
14.5 %
11.9 %
13.2 %
11.8 %
View original content to download multimedia:https://www.prnewswire.com/news-releases/happen-inc-reports-second-quarter-2026-results-302835538.html
SOURCE Happen, Inc.
You may like
Technology
Amid Rising Costs and Surgical Disruptions in ASCs, NorthStar Anesthesia Strengthens Focus on ASC Partnerships
Published
28 minutes agoon
October 23, 2026By
With 17 new ASC partnerships nationwide to date in 2026, NorthStar Anesthesia emphasizes proactive patient assessment, reliable staffing, and clinical consistency to help surgery centers reduce preventable cancellations and maximize surgical capacity.
IRVING, Texas, Oct. 23, 2026 /PRNewswire/ — As ambulatory surgery centers (ASCs) face mounting financial pressures, staffing challenges, and increasingly complex patient needs, anesthesia has emerged as a critical partner in their ability to operate efficiently and sustainably. NorthStar Anesthesia is addressing these challenges through a dedicated ASC model designed to reduce preventable case cancellations, improve surgical throughput, and help centers make the most of their existing operating room capacity.
“The challenge for ASCs today isn’t simply finding anesthesia coverage. It’s ensuring that coverage translates into reliable surgical capacity,” said Cindy Myers, Vice President of ASC Operations at NorthStar Anesthesia. “When cases are cancelled unnecessarily or operating rooms aren’t running as planned, the impact extends well beyond the anesthesia department. Our focus is on helping centers address those challenges systematically, so they can deliver more consistent care and operate more efficiently.”
Reducing Preventable Cancellations Through Better Preparation
One of the most significant opportunities to improve ASC performance lies in the preoperative process. When potential anesthesia concerns are not identified until the day of surgery, patients may face unexpected cancellations, surgeons lose valuable operating time, and centers absorb the cost of unused capacity.
NorthStar addresses this challenge through ASC-specific pre-anesthesia testing (PAT) guidelines and standardized clinical protocols designed to identify potential issues earlier, facilitate appropriate patient optimization, and support consistent decision-making across the surgical process.
“In ambulatory surgery, the decisions made before the patient arrives are often just as important as those made in the operating room,” said Gajan Mahendran, MD, Vice President of Physician Services at NorthStar Anesthesia. “A consistent, evidence-based approach to preoperative assessment helps us identify risks earlier, determine which patients are appropriate for the ASC setting, and address potential barriers to surgery in advance. That means fewer last-minute surprises and a better experience for patients, surgeons, and facilities.”
Aligning Anesthesia Resources With Surgical Demand
Alongside clinical challenges, ASCs are navigating a changing economic environment. In a recent Becker’s ASC Review interview, NorthStar CEO Adam Spiegel noted that approximately 80% of ASCs in NorthStar’s network now require anesthesia stipends, compared with just 10% to 15% before the pandemic.
As anesthesia costs rise, ensuring that staffing levels align with actual surgical demand has become increasingly important. NorthStar works with ASC partners to develop staffing models that reflect each facility’s case mix, surgical volume, and operating requirements. “Adding anesthesia resources doesn’t automatically improve performance if those resources aren’t aligned with the center’s surgical volume,” Myers said. “We work closely with our partners to understand their schedules, case mix, and operational needs so we can build a model that supports both reliable access to care and financial sustainability.”
Combining National Resources With Local Clinical Expertise
As ASCs take on a greater share of surgical procedures, the demands placed on anesthesia providers are becoming more complex. Smaller or locally managed anesthesia groups may face challenges maintaining consistent coverage, recruiting clinicians, or investing in standardized clinical and operational processes.
NorthStar’s model combines local clinical leadership with national recruiting capabilities, dedicated ASC operations expertise, and established quality guidelines. This infrastructure helps support continuity of care, consistent clinical practices, and the flexibility to respond to changes in surgical demand.
The approach is reflected in NorthStar’s expanding ASC partnerships. To date in 2026 alone, NorthStar has added 17 ASC partnerships, including CarePlex Orthopaedic Ambulatory Surgery Center in Norfolk, Virginia; Stony Point Surgery Center and West Creek Surgery Center, both part of MedRVA Healthcare in Richmond, Virginia; an Orthopedic Surgery Center in Wisconsin; Eye Surgery Center of Homewood in Homewood, Alabama; and The Toledo Clinic ASC in Toledo, Ohio.
These partnerships reflect the growing importance of anesthesia providers that can address both the clinical and operational needs of outpatient surgery centers.
To learn more and to request a confidential anesthesia program assessment, please contact James Bagliani, Director of Business Development, NorthStar Anesthesia at james.bagliani@northstaranesthesia.com.
About NorthStar Anesthesia
NorthStar Anesthesia is a company of caregivers, founded by an anesthesiologist and a Certified Registered Nurse Anesthetist (CRNA). With more than 4,000 anesthesiologists and CRNAs under its banner, NorthStar partners with more than 280 healthcare client sites across more than 20 states and counting to deliver a more productive and efficient model of anesthesia care. Its care team approach focuses on the provision of high-quality care while measurably improving operating room performance.
Media Contact: James Bagliani, Director of Business Development, NorthStar Anesthesia james.bagliani@northstaranesthesia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/amid-rising-costs-and-surgical-disruptions-in-ascs-northstar-anesthesia-strengthens-focus-on-asc-partnerships-302918226.html
SOURCE NorthStar Anesthesia
Technology
Dimethylaminopropylamine Market to Reach USD 731.9 Million by 2035 on Surfactant and Epoxy Demand, Credence Research Finds
Published
28 minutes agoon
October 23, 2026By
LONDON, Oct. 23, 2026 /PRNewswire/ — Credence Research Inc. has added the “Dimethylaminopropylamine Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035” study to its market intelligence portfolio. The report examines market value, segmentation, demand drivers, regional dynamics, competition and recent industry developments.
The dimethylaminopropylamine (DMAPA) market was valued at USD 452.6 million in 2025 and is projected to reach USD 731.9 million by 2035, representing a 4.92% compound annual growth rate over 2025–2035, according to Credence Research. The firm estimates 2026 revenue at USD 474.3 million. Asia Pacific accounted for the largest modeled geographic share at 44.0% in 2025, while Asia Pacific is projected to grow fastest at 5.88% annually. Market sizes, regional shares and segment shares are Credence Research estimates rather than independently audited industry totals.
Key Takeaways
The market is forecast to increase from USD 452.6 million in 2025 to USD 731.9 million by 2035, with a reported CAGR of 4.92%.Asia Pacific led the modeled 2025 geography with 44.0%; Asia Pacific has the fastest forecast geographic growth of 5.88%.By application, Surfactants accounted for 61.0% of modeled 2025 value, while Epoxy curing agents is forecast to grow at 5.66% a year.By end-use industry, Personal care and cosmetics accounted for 44.0% of modeled 2025 value, while Paints, coatings and composites is forecast to grow at 5.61% a year.The market definition excludes adjacent product or transaction value where that spending is outside the report’s measured scope.
Scope & Segmentation – Dimethylaminopropylamine Market
The study values sales of 3-(dimethylamino)-1-propylamine, an amine intermediate produced from dimethylamine and acrylonitrile. Included uses span betaine and amine-oxide surfactants, epoxy curing agents, polyurethane catalysts, water treatment chemicals, agrochemical intermediates and lubricant additives. Finished surfactants, coatings and other downstream products are excluded from the DMAPA revenue estimate.
By application: Surfactants (betaines and amine oxides); Epoxy curing agents; Polyurethane catalysts; Water treatment chemicals; Agrochemical intermediates; Fuel and lubricant additives; Others.By end-use industry: Personal care and cosmetics; Home care and institutional cleaning; Paints, coatings and composites; Water treatment; Agriculture; Automotive and lubricants.By geography: Asia Pacific; Europe; North America; Latin America; Middle East and Africa.
Read the complete report and request a sample: https://www.credenceresearch.com/report/dimethylaminopropylamine-market
Why This Report Matters
The study distinguishes a narrowly defined revenue pool from adjacent activity that can inflate comparisons between research estimates. This helps strategy teams compare suppliers, customer budgets and product categories on a consistent basis.The base-year segment mix identifies where current purchasing is concentrated, while the modeled faster-growing categories help evaluate investment timing and market entry.Geographic shares are proprietary estimates; company and regulatory announcements are used to explain demand mechanisms, not to independently verify global market totals.
Market Overview
The study values sales of 3-(dimethylamino)-1-propylamine, an amine intermediate produced from dimethylamine and acrylonitrile. Included uses span betaine and amine-oxide surfactants, epoxy curing agents, polyurethane catalysts, water treatment chemicals, agrochemical intermediates and lubricant additives. Finished surfactants, coatings and other downstream products are excluded from the DMAPA revenue estimate.
DMAPA is a building block for cocamidopropyl betaine and related surfactants used in shampoos, body washes and dishwashing products. Producers serving consumer brands require consistent quality and supply, so the largest application tends to support repeat orders rather than episodic equipment-style purchases.
The outlook reflects expected changes in customer adoption, procurement, technology and regulation. It should be read as a modeled scenario, not as a guarantee of sales or company performance.
Key Attributes
Attribute
Details
Base year
2025
Historical reference
2018–2025
2025 market size
USD 452.6 million
2026 estimate
USD 474.3 million
2035 market forecast
USD 731.9 million
Reported CAGR
4.92% (2025–2035)
Geographic scope
Global
Primary source
https://www.credenceresearch.com/report/dimethylaminopropylamine-market
Segmentation
By application
The study divides this category into surfactants (betaines and amine oxides); epoxy curing agents; polyurethane catalysts; water treatment chemicals; agrochemical intermediates; fuel and lubricant additives; others. Surfactants led the 2025 value mix with 61.0%. Epoxy curing agents is the fastest-growing modeled subsegment at 5.66% a year. These shares represent Credence Research model outputs, not audited supplier sales.
By end-use industry
The study divides this category into personal care and cosmetics; home care and institutional cleaning; paints, coatings and composites; water treatment; agriculture; automotive and lubricants. Personal care and cosmetics led the 2025 value mix with 44.0%. Paints, coatings and composites is the fastest-growing modeled subsegment at 5.61% a year. These shares represent Credence Research model outputs, not audited supplier sales.
Market Growth Drivers
Mild cleansing formulas sustain high-volume demand
DMAPA is a building block for cocamidopropyl betaine and related surfactants used in shampoos, body washes and dishwashing products. Producers serving consumer brands require consistent quality and supply, so the largest application tends to support repeat orders rather than episodic equipment-style purchases.
Epoxy hardeners provide a faster-growth outlet
DMAPA-based amidoamines are used in epoxy curing systems for floors, protective coatings and composite applications. Wind blade production and industrial maintenance provide additional demand. The report models epoxy curing agents as the fastest-growing application, although their value starts below surfactants.
Capacity integration shapes producer economics
The chemical route depends on dimethylamine and acrylonitrile, making feedstock access and energy costs important. Integrated producers can manage these inputs and purity requirements more directly, while regional buyers value dependable supply and local technical support.
Regional Analysis
Asia Pacific held 44.0% of modeled 2025 revenue, while Asia Pacific is expected to record the fastest regional growth at 5.88%. The allocation follows the study’s defined buyer or provider-revenue scope.
Asia Pacific
Asia Pacific represented 44.0% of modeled 2025 market value. China hosts extensive betaine and epoxy manufacturing and new intermediate capacity. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
Europe
Europe represented 23.0% of modeled 2025 market value. Specialty formulations and high-purity specifications sustain demand. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
North America
North America represented 21.0% of modeled 2025 market value. Personal care, coating and water treatment buyers support a mature market. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
Latin America
Latin America represented 7.0% of modeled 2025 market value. Brazilian and Mexican cleaning and personal care production expands. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
Middle East and Africa
Middle East and Africa represented 5.0% of modeled 2025 market value. Industrial chemicals and water treatment provide emerging outlets. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
Market Challenges
Input prices and possible overcapacity
Changes in acrylonitrile and dimethylamine costs can pressure margins. New Asian capacity could also exceed near-term demand, creating price competition, especially for producers that lack integrated feedstock or differentiated purity grades.
Handling and product-purity requirements
DMAPA is a hazardous industrial intermediate requiring careful handling. Residual amines in downstream betaines can create sensitization concerns, so cosmetics customers increasingly emphasize analytical control, specifications and supplier qualification.
Future Outlook
Asia Pacific should remain the main production and demand center, with surfactants anchoring volume and epoxy applications contributing above-average growth. Supplier positioning will depend on feedstock integration, reliable logistics, high-purity grades and the pace at which new capacity is absorbed.
Competitive Landscape
BASF and Eastman Chemical are identified as integrated DMAPA producers, while Zhangjiagang Feixiang Chemical and Zhejiang Xinhua Chemical participate in Chinese production. Huntsman is relevant to downstream amine chemistry. Solvay, Evonik and Kao are better described as converters or customers for DMAPA-based surfactants rather than direct merchant DMAPA producers. No credible company-specific DMAPA revenue ranking is available.
Key Players
BASF; Eastman Chemical; Zhangjiagang Feixiang Chemical; Zhejiang Xinhua Chemical; Huntsman (downstream derivatives); Solvay (surfactants); Evonik (surfactants); Kao (surfactants)
Recent Developments
Oct. 16, 2025: BASF said the July start-up of expanded DMAPA production in Nanjing nearly doubled the site’s annual capacity and raised BASF’s global DMAPA capacity by more than 20% to approximately 85,000 metric tons.July 2025: As part of the same Nanjing project, BASF expanded polyetheramine capacity by about 25%. This is a related amine-chain investment, not an additional DMAPA plant.
Report Coverage
The study provides market estimates for 2025 and 2035, a 2026 interim estimate, analysis of the defined product and service scope, segment and geographic revenue shares, demand drivers, technology changes, competitive roles, constraints and recent dated developments. The reported CAGR and regional shares are based on Credence Research’s market model. Company announcements are contextual evidence and should not be interpreted as independent verification of the forecast.
Read the complete report and request a sample: https://www.credenceresearch.com/report/dimethylaminopropylamine-market
Related Reports
https://www.credenceresearch.com/report/apac-infectious-enteritis-treatment-market
https://www.credenceresearch.com/report/australia-digital-therapeutics-market
https://www.credenceresearch.com/report/australia-corporate-education-and-upskilling-market
https://www.credenceresearch.com/report/prescription-drugs-market
https://www.credenceresearch.com/report/orthopedic-devices-market
https://www.credenceresearch.com/report/parkinsons-disease-therapeutics-market
https://www.credenceresearch.com/report/plasma-derived-therapy-market
https://www.credenceresearch.com/report/over-the-counter-drugs-market
https://www.credenceresearch.com/report/orphan-drugs-market
https://www.credenceresearch.com/report/pediatric-drugs-market
https://www.credenceresearch.com/report/pain-management-drugs-market
https://www.credenceresearch.com/report/osteoporosis-drugs-market
https://www.credenceresearch.com/report/patient-monitoring-devices-market
https://www.credenceresearch.com/report/australia-drive-by-wire-market
https://www.credenceresearch.com/report/australia-cold-chain-and-refrigerated-transport-market
https://www.credenceresearch.com/report/australia-critical-illness-insurance-market
https://www.credenceresearch.com/report/australia-eco-friendly-labels-market
https://www.credenceresearch.com/report/apac-healthcare-digital-twins-market
https://www.credenceresearch.com/report/australia-driveline-components-market
About Us
Credence Research Inc. is a global market intelligence and consulting firm founded in 2015. It provides quantitative market research, competitive intelligence and strategic advisory services to businesses, investors and other organizations. Its research draws on primary and secondary information, industry interviews and structured market models.
The firm analyzes market size, growth drivers, segmentation, regional opportunities, supply chains and competitive positioning across industrial, technology, energy, health care and consumer markets. Its studies help clients evaluate strategic and investment decisions with documented assumptions and industry context.
Contact Us
Credence Research Inc.
Tower C-1105, S 25, Akash Tower
Vishal Nagar, Pimple Nilakh, Haveli, Pune 411027, India
USA: +1-888-600-6441
sales@credenceresearch.com
www.credenceresearch.com
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/dimethylaminopropylamine-market-to-reach-usd-731-9-million-by-2035-on-surfactant-and-epoxy-demand-credence-research-finds-302918151.html
Technology
Misty Ventures and Aplicata Technologies Announce Strategic Partnership to Pursue Canadian Defence Opportunities
Published
28 minutes agoon
October 23, 2026By
Together, Aplicata and Misty Ventures will leverage their respective expertise, networks, and resources to support the commercialization of innovative technologies and help bring impactful solutions to government and public-sector markets.
SASKATOON, SK, Oct. 23, 2026 /PRNewswire-PRWeb/ — Misty Ventures, the economic development arm of Mistawasis Nêhiyawak, and Aplicata Technologies, a trusted leader in high-performance computing platforms for mission-critical defence applications, today announced they have signed a Memorandum of Understanding to explore a strategic partnership focused on pursuing and strengthening Canadian defence market opportunities.
Aplicata and Misty Ventures have agreed to form a Saskatchewan-based joint venture to develop and commercialize electronic warfare (EW), signals intelligence (SIGINT) and intelligence, surveillance and reconnaissance (ISR) technologies for Canadian defence.
The joint venture will deliver solutions across uncrewed aerial vehicles, aircraft, ground vehicles and naval vessels, providing the Canadian Armed Forces with a decisive operational advantage through advanced, mission-critical technology. It brings together Aplicata’s engineering, manufacturing and market expertise with Misty Ventures’ business development experience and its access to skilled talent and defence markets.
A guiding principle of the partnership is to build upon the strong business acumen, entrepreneurial capacity, and strategic vision of Mistawasis Nêhiyawak and its affiliated Indigenous communities. Through this partnership, Mistawasis Nêhiyawak seeks to leverage these strengths to contribute meaningfully to Canada’s defence priorities, supporting the development of sovereign capabilities, domestic innovation, and resilient Canadian supply chains. In addition to technology licensing, Aplicata intends to support the partnership through advanced knowledge and skills development, enabling Mistawasis Nêhiyawak to further expand its participation in Canada’s defence and security ecosystem and create lasting economic opportunity.
“This partnership reflects our commitment to building long-term, sustainable economic opportunities for Mistawasis Nêhiyawak and our broader community,” said Robert Daniels, Chief Executive Officer of Misty Ventures. “By combining our experience and market reach with Aplicata’s proven technology and market expertise, we believe we can create a defence sector business that delivers real value for Canada while creating meaningful opportunities for our people.”
“Aplicata brings a long history of innovation in advanced technologies for defence,” said Mohammad Darwish, Chief Executive Officer of Aplicata Technologies. “Partnering with Misty Ventures allows us to bring our capabilities to the Canadian defence market in a way that also creates lasting economic benefit for Mistawasis Nêhiyawak. We’re excited about the opportunity to build something meaningful together.”
About Misty Ventures
Since 2015, Misty Ventures has been the economic development entity of Mistawasis Nêhiyawak, growing through strategic partnerships across Saskatchewan’s construction, mining, oil and gas, and renewable energy sectors. Misty Ventures continues to pursue investments and collaborations aligned with its vision, mission, and values.
About Aplicata Technologies
Aplicata is a trusted leader in high-performance computing platforms for mission-critical defence applications. We create innovative solutions engineered for performance and reliability, delivering results our customers can depend on. Rooted in a culture of collaboration and driven by a shared sense of purpose, we serve government and commercial organizations alike, pushing the boundaries of technology to enable new possibilities.
Media Contact
Media Relations, Aplicata Technologies, 1 (844) 250-6300, media@aplicata.com, www.aplicata.com
View original content to download multimedia:https://www.prweb.com/releases/misty-ventures-and-aplicata-technologies-announce-strategic-partnership-to-pursue-canadian-defence-opportunities-302917752.html
SOURCE Aplicata Technologies
Amid Rising Costs and Surgical Disruptions in ASCs, NorthStar Anesthesia Strengthens Focus on ASC Partnerships
Dimethylaminopropylamine Market to Reach USD 731.9 Million by 2035 on Surfactant and Epoxy Demand, Credence Research Finds
Misty Ventures and Aplicata Technologies Announce Strategic Partnership to Pursue Canadian Defence Opportunities
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days agoGMIF2026: AI Inference Powers the “Token Factory” and Drives System-Level Rethinking of Memory & Storage
-
Technology4 days agoInstaMall Launches Same-Day Fashion Delivery Experience, Bringing 80+ Brands to Shoppers’ Doors in Miami
-
Technology5 days agoHISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES
-
Coin Market4 days agoWorld Liberty’s USD1 stablecoin sheds $400M in market cap in two weeks
-
Technology4 days agoTruecaller announces preliminary numbers for the third quarter 2026
-
Technology4 days agoSALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
-
Technology4 days agoTrend Micro Announces Up to ¥10 Billion toward Cyber Resilience Initiative to Strengthen Security for Japanese Organizations in the AI Era
-
Technology4 days agoTreasuries Rallied as Tech Slid, and the Crowded Bet Against Bonds Felt It